Canada markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1200-0.0100 (-7.69%)
At close: 03:54PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 17.14M
Enterprise Value 25.64M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)110.92
Price/Book (mrq)107.98
Enterprise Value/Revenue 172.12
Enterprise Value/EBITDA -8.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.55
52-Week Change 318.18%
S&P500 52-Week Change 324.19%
52 Week High 30.1700
52 Week Low 30.0500
50-Day Moving Average 30.1174
200-Day Moving Average 30.0878

Share Statistics

Avg Vol (3 month) 3184.5k
Avg Vol (10 day) 3367.04k
Shares Outstanding 5131.84M
Implied Shares Outstanding 6131.84M
Float 884.8M
% Held by Insiders 134.93%
% Held by Institutions 10.00%
Shares Short (Apr 15, 2024) 417.63k
Short Ratio (Apr 15, 2024) 40.07
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.01%
Shares Short (prior month Mar 15, 2024) 42.63k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 13, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 13, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,248.93%

Management Effectiveness

Return on Assets (ttm)-37.06%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)148.98k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.23M
Net Income Avi to Common (ttm)-4.56M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)749.25k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)9.26M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.34
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-3.22M
Levered Free Cash Flow (ttm)-1.45M